These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 28297151)

  • 21. Glucocorticoid action and the clinical features of Cushing's syndrome.
    Yanovski JA; Cutler GB
    Endocrinol Metab Clin North Am; 1994 Sep; 23(3):487-509. PubMed ID: 7805650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The changes in renin-angiotensin-aldosterone-system in different subtypes of Cushing's syndrome].
    Cui J; Dou J; Yang G; Zang L; Jin N; Chen K; Du J; Gu W; Wang X; Yang L; Lyu Z; Ba J; Mu Y; Lu J; Li J; Pan C
    Zhonghua Nei Ke Za Zhi; 2015 Jul; 54(7):618-22. PubMed ID: 26359025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cushing's syndrome after intralesional triamcinolone acetonide: a systematic review of the literature and multinational survey.
    Fredman R; Tenenhaus M
    Burns; 2013 Jun; 39(4):549-57. PubMed ID: 23092701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [CHALLENGES IN THE DIAGNOSIS OF CUSHING'S SYNDROME IN THE MODERN ERA].
    Saiegh L; Sheikh-Ahmad M; Reut M; Jubran Y; Shechner C
    Harefuah; 2015 Dec; 154(12):791-4, 803. PubMed ID: 26897783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exogenous Cushing syndrome due to misuse of potent topical steroid.
    Özgüç Çömlek F; Örüm S; Aydın S; Tütüncüler F
    Pediatr Dermatol; 2018 Mar; 35(2):e121-e123. PubMed ID: 29315782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Martin NM; Dhillo WS; Meeran K
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):476. PubMed ID: 17581261
    [No Abstract]   [Full Text] [Related]  

  • 28. Prolonged childhood Cushing's syndrome secondary to intralesional triamcinolone acetonide.
    Teelucksingh S; Balkaran B; Ganeshmoorthi A; Arthur P
    Ann Trop Paediatr; 2002 Mar; 22(1):89-91. PubMed ID: 11926057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cushing's syndrome.
    Shibli-Rahhal A; Van Beek M; Schlechte JA
    Clin Dermatol; 2006; 24(4):260-5. PubMed ID: 16828407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exogenous Cushing Syndrome due to Topical Clobetasone use for Diaper Rash.
    Jevalikar G; Sharma O
    Indian Pediatr; 2016 Jan; 53(1):76-7. PubMed ID: 26840685
    [No Abstract]   [Full Text] [Related]  

  • 31. Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome.
    Papanicolaou DA; Mullen N; Kyrou I; Nieman LK
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4515-21. PubMed ID: 12364428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone deficiency in treated acromegaly and active Cushing's syndrome.
    Formenti AM; Maffezzoni F; Doga M; Mazziotti G; Giustina A
    Best Pract Res Clin Endocrinol Metab; 2017 Feb; 31(1):79-90. PubMed ID: 28477735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevalence, etiology and clinical findings of Cushing's syndrome].
    Lahera Vargas M; da Costa CV
    Endocrinol Nutr; 2009 Jan; 56(1):32-9. PubMed ID: 19627706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nocturnal 8 mg dexamethasone suppression test: a practical and accurate test for identification of the cause of endogenous Cushing's syndrome.
    Sriussadaporn S; Ploybutr S; Peerapatdit T; Plengvidhya N; Nitiyanant W; Vannasaeng S; Vichayanrat A
    Br J Clin Pract; 1996; 50(1):9-13. PubMed ID: 8729595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cushing's syndrome].
    Guignat L; Bertagna X; Bertherat J
    Rev Prat; 2008 May; 58(9):957-65. PubMed ID: 18672661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cushing syndrome caused by topical corticosteroid: a case report.
    Gen R; Akbay E; Sezer K
    Am J Med Sci; 2007 Mar; 333(3):173-4. PubMed ID: 17496736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are the effects of local treatment with glucocorticoids only local?
    van Tuyl SA; Slee PH
    Neth J Med; 2002 Apr; 60(3):130-2. PubMed ID: 12164369
    [No Abstract]   [Full Text] [Related]  

  • 39. Incompatibility between fasting and postprandial plasma glucose in patients with Cushing's syndrome.
    Otsuki M; Kitamura T; Tamada D; Tabuchi Y; Mukai K; Morita S; Kasayama S; Shimomura I; Koga M
    Endocr J; 2016 Nov; 63(11):1017-1023. PubMed ID: 27498594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary free cortisol in the diagnosis of Cushing's syndrome: how useful?
    Odeniyi IA; Fasanmade OA
    Niger J Clin Pract; 2013; 16(3):269-72. PubMed ID: 23771444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.